Previous close | 6.16 |
Open | 6.13 |
Bid | 6.08 x 100 |
Ask | 6.20 x 100 |
Day's range | 5.99 - 6.29 |
52-week range | 5.84 - 21.42 |
Volume | |
Avg. volume | 1,310,118 |
Market cap | 516.125M |
Beta (5Y monthly) | 1.70 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Verve Therapeutics (VERV) delivered earnings and revenue surprises of 13.24% and 12.77%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Disc Medicine, Inc. (IRON) and Verve Therapeutics (VERV) fall on study updates.